<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83943EFB-3518-459A-B681-62475A559C89"><gtr:id>83943EFB-3518-459A-B681-62475A559C89</gtr:id><gtr:name>Whitehead Institute for Biomedical Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83ED8C3A-B95B-44DE-B95F-DB7176D94CBC"><gtr:id>83ED8C3A-B95B-44DE-B95F-DB7176D94CBC</gtr:id><gtr:name>Illumina</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DF728C56-E167-43F3-9021-C365306BD658"><gtr:id>DF728C56-E167-43F3-9021-C365306BD658</gtr:id><gtr:name>Genera Clinica Valle Giulia</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:department>Brighton and Sussex Medical School</gtr:department><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83943EFB-3518-459A-B681-62475A559C89"><gtr:id>83943EFB-3518-459A-B681-62475A559C89</gtr:id><gtr:name>Whitehead Institute for Biomedical Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83ED8C3A-B95B-44DE-B95F-DB7176D94CBC"><gtr:id>83ED8C3A-B95B-44DE-B95F-DB7176D94CBC</gtr:id><gtr:name>Illumina</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DF728C56-E167-43F3-9021-C365306BD658"><gtr:id>DF728C56-E167-43F3-9021-C365306BD658</gtr:id><gtr:name>Genera Clinica Valle Giulia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82200E1A-04DA-42F5-80F3-B0FF026643BD"><gtr:id>82200E1A-04DA-42F5-80F3-B0FF026643BD</gtr:id><gtr:name>University of Copenhagen</gtr:name><gtr:address><gtr:line1>Norregade 10</gtr:line1><gtr:line2>Postboks 2177</gtr:line2><gtr:line4>Copenhagen K</gtr:line4><gtr:line5>DK-1017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/47AB1AF8-A5B1-4772-B652-93734E275118"><gtr:id>47AB1AF8-A5B1-4772-B652-93734E275118</gtr:id><gtr:firstName>Eva</gtr:firstName><gtr:otherNames>Ran</gtr:otherNames><gtr:surname>Hoffmann</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0902043"><gtr:id>8681BF05-83A3-407A-9F5A-9E9761A4FF8C</gtr:id><gtr:title>Chromosome dynamics during the G2/M transition in meiosis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0902043</gtr:grantReference><gtr:abstractText>During the production of sperm and eggs, cells have to half the number of chromosomes, otherwise the resulting foetus will contain too many. This requires a specialized cell division where chromosomes first find their partner and then split from them- a marriage followed by divorce. How do cells ensure that each egg or sperm contains exactly one full set of chromosomes, 23 in the case of humans? Chromosomes pair on the basis of sequence identity and form specialized connections called chiasmata that look like the Greek letter chi under the microscope. Pairing and the formation of chiasmata is facilitated by a structure called the synaptonemal complex; when chiasmata form the synaptonemal complex is broken down and cells get ready to split up the chromosome pairs. We are investigating how the breakdown of the synaptonemal complex is facilitated and how is it coordinated with formation of chiasmata. To this end, we use baker?s yeast as a model organism. Baker?s yeast has provided valuable insight into how chiasmata and the synaptonemal complex are formed and we expect that some of the basic principles that govern its breakdown will also be relevant in humans.</gtr:abstractText><gtr:technicalSummary>The synaptonemal complex is a tripartite proteinaceous structure that connects homologous chromosomes lengthwise during midprophase/pachytene. Its disassembly is the first, dramatic hallmark of the progression of cells to the first meiotic nuclear division. At this time, crossovers are observed in molecular assays and chiasmata become cytologically distinguishable. Monopolin loading has also taken place, facilitating that sister kinetochores co-orient. All of these events promote homologous chromosomes to segregate to opposite poles during the first meiotic division, thereby avoiding aneuploidy formation in the gametes. We propose to determine how these events coordinated with cell cycle progression. We have recently demonstrated that two highly conserved kinases, Ipl1/Aurora kinase and Cdc5/Polo-like kinase, promote SC disassembly. In ipl1Aurora mutants, SCs are retained in 80% of cells that have transited to diplotene or metaphase I. However, crossover completion and cell cycle progression occur normally, suggesting that Ipl1Aurora links SC disassembly to other events occurring upon pachytene exit. The SC disassembly defect is different in cdc5Polo mutants: numerous, distinct, SC foci are retained at post-pachytene stages. These observations suggest that SCs may not be homogenous structures and that at least two mechanisms promote disassembly. In this programme of work, we propose to study SC disassembly and the integration with crossover formation in the model organism budding yeast. Budding yeast has proved a very good model for understanding crossing over and the SC in higher organisms, including mammals. We have designed cytological, molecular, and proteomic experiments to assess how the SC disassembles, where in the genome Zip1 is retained in the ipl1Aurora and cdc5Polo mutants and how Ipl1Aurora might be regulated. Furthermore, we have developed protein kinase assays that should allow us to identify Ipl1Aurora and Cdc5Polo-specific phosphorylation events, with a view to understand the mechanistic regulation of SC disassembly and crossover formation. We have set up relevant collaborations for the various techniques with world leaders in their fields in order to maximize the probability of success. We envision that our studies will provide valuable insights into a basic biological phenomenon in addition to generating a good model system for understanding meiotic regulation in humans.</gtr:technicalSummary><gtr:fund><gtr:end>2016-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1846757</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Whitehead Institute for Biomedical Research</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Hochwagen</gtr:description><gtr:id>F58C39E9-428E-403B-9A6D-039552A928CE</gtr:id><gtr:impact>see publication by Falk et al., Dev. Cell</gtr:impact><gtr:outcomeId>Exda64WB6zX-1</gtr:outcomeId><gtr:partnerContribution>Has contributed with microarray analysis</gtr:partnerContribution><gtr:piContribution>Research: Genetic and c ytological observations. Ideas: direct hypothesis formulation. Paper writing: contribution towards individual sections.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genera Clinica Valle Giulia</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>GENERA Reproductive Centers, Rome, Italy</gtr:description><gtr:id>4595D84C-0FF9-4333-B051-E6B66FD3A11B</gtr:id><gtr:impact>The collaboration has had several outputs, including two publications and the introduction of Meiomapping to preclinical assessment to methods used for assisted reproductive Technologies (ART). The collaboration and include informaticians, embryologists, clinical gynecologists, and basic biomedical researchers.</gtr:impact><gtr:outcomeId>58496e49a7b826.30296064-1</gtr:outcomeId><gtr:partnerContribution>GENERA provide some types of clinical material and will carry out the primary data analysis in ISO-accredited settings.</gtr:partnerContribution><gtr:piContribution>We provide some types of clinical material, technology equipment, and the basic knowledge base from the Chromosome Biology field to enhance clinical research and treatment methods.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Illumina</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:department>Reproductive &amp; Genetic Health</gtr:department><gtr:description>Reproductive Health Group, Illumina Ltd.</gtr:description><gtr:id>8E81DBAF-D748-4026-AD44-DAEAB3CA9586</gtr:id><gtr:impact>Several outputs have been achieved during the proof-of-principle phase. They include a patent (Illumina), development of new methodology for reproductive health and their clinical validation as well as basic science (Ottolini et al., Nature Genetics, 2015). The partnership is also training two UK-based postdocs, embryologists, PhD students across disciplines in emerging technologists for human reproductive health and single cell omics.</gtr:impact><gtr:outcomeId>56cc6aae8b5bd0.79022115-1</gtr:outcomeId><gtr:partnerContribution>Illumina has contributed Financial resources as well as expertise and knowledge to this partnership. This includes a full-funded PhD student, who is registered at the University of Sussex. The partnership has access to Illumina's equipment and reagents at its site in Fulbourn.</gtr:partnerContribution><gtr:piContribution>We collaborate with Illumina Ltd. to develop and implement single-cell genomics for reproductive health purposes. This includes the knowledge base of basic chromosome biology as well as training of students and postdocs across industry and academic settings.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Brighton Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>17F103A6-155E-415D-932B-25C3EE036DF0</gtr:id><gtr:impact>Participated at stall demonstrating DNA to the general public

General interest in genetics</gtr:impact><gtr:outcomeId>666F6F77DF9</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>3500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Undergraduate summerstudentship</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>The Genetics Society</gtr:fundingOrg><gtr:id>0392C479-4DB5-42C5-9E02-EFB071C48DCC</gtr:id><gtr:outcomeId>q7VYc9M6G4a</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000000</gtr:amountPounds><gtr:country>Denmark, Kingdom of</gtr:country><gtr:currCode>DKK</gtr:currCode><gtr:currCountryCode>Denmark</gtr:currCountryCode><gtr:currLang>da_DK</gtr:currLang><gtr:department>Novo Nordisk Foundation</gtr:department><gtr:description>Novo Nordisk Foundation Young Investigator Award</gtr:description><gtr:end>2022-12-02</gtr:end><gtr:fundingOrg>Novo Nordisk</gtr:fundingOrg><gtr:id>D3373B21-864B-48AD-B65C-E459E56DB5BC</gtr:id><gtr:outcomeId>56cc6b2f6a1566.07852676</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EU7 COMREC</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>E99629F3-4AF5-49F2-A33A-CE3460E22AEC</gtr:id><gtr:outcomeId>56cd66160922a0.32915153</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Preclinical assessment for new assisted reproductive technologies (ART)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>F00DBE73-1ED4-43A8-A940-33CD094D7834</gtr:id><gtr:outcomeId>584ef4e9f208c0.73461752</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed single-cell genomics to study chromosomes and genetic quality of human eggs and embryos directly. Briefly, we can separate and isolate all three cells from single meioses in human adult oocytes or use a small sample from human embryos to assess the genetic quality (chromosome number, recombination).</gtr:description><gtr:id>F3527A67-9A78-451D-9652-82888FF4E038</gtr:id><gtr:impact>MeioMapping facilitates a preclinical validation methods of reproductive health products in assisted reproductive technology settings, which is currently poorly developed. For example, methods to mature eggs in vitro, activate eggs in vitro, and toxicological assays can now be performed directly on human material.</gtr:impact><gtr:outcomeId>56cd676abf6210.08823632</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Single cell genomics- human eggs and embryos</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>This is a machine learning algorithm that detects how scientists are selecting foci, when manually scoring them, and that can be trained to mimic their detection.</gtr:description><gtr:id>BADE4FA0-746A-40D3-A7B6-4B73522984A0</gtr:id><gtr:impact>Many groups are using this product to standardize foci count in cytological preparations.</gtr:impact><gtr:outcomeId>56cd683d677335.02249891</gtr:outcomeId><gtr:title>FindFoci</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.sussex.ac.uk/gdsc/intranet/microscopy/imagej/findfoci</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C32FA4FA-1C0D-4DDE-9DA3-A92F01DF8C02</gtr:id><gtr:title>Chromosome recombination.</gtr:title><gtr:parentPublicationTitle>Seminars in cell &amp; developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d2f6966da4d1a7b479d930cf96d7945"><gtr:id>0d2f6966da4d1a7b479d930cf96d7945</gtr:id><gtr:otherNames>Hoffmann E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1084-9521</gtr:issn><gtr:outcomeId>pm_14722_22_22037628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>674F4443-8EEE-4DA3-8014-D371A9126BFA</gtr:id><gtr:title>Genome-wide maps of recombination and chromosome segregation in human oocytes and embryos show selection for maternal recombination rates.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ea4df14dbf27b4e8a0fd4c0a54597e3"><gtr:id>2ea4df14dbf27b4e8a0fd4c0a54597e3</gtr:id><gtr:otherNames>Ottolini CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5675e4ab7a8a1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>240BFB11-8967-49DD-87C0-280F353C7292</gtr:id><gtr:title>Ipl1/Aurora kinase suppresses S-CDK-driven spindle formation during prophase I to ensure chromosome integrity during meiosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64291a29c963e169f0527740456ea41a"><gtr:id>64291a29c963e169f0527740456ea41a</gtr:id><gtr:otherNames>Newnham L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54516ef5782996.87935718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AD197B7-B1C3-4D34-9566-7EC8D781AACA</gtr:id><gtr:title>FindFoci: a focus detection algorithm with automated parameter training that closely matches human assignments, reduces human inconsistencies and increases speed of analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/468b3141f629b1c74894ba5cfc45311c"><gtr:id>468b3141f629b1c74894ba5cfc45311c</gtr:id><gtr:otherNames>Herbert AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_55f98598547234eb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F095858-5167-4B46-8107-4A720E7C3E02</gtr:id><gtr:title>A Mec1- and PP4-dependent checkpoint couples centromere pairing to meiotic recombination.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43d9f7f386fbf27ebaba97071c34c832"><gtr:id>43d9f7f386fbf27ebaba97071c34c832</gtr:id><gtr:otherNames>Falk JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>mfjdSiZXQrs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9AD0F4E-5FE5-4980-9AC1-6E60163C33E4</gtr:id><gtr:title>Monopolin subunit Csm1 associates with MIND complex to establish monopolar attachment of sister kinetochores at meiosis I.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caf3d032b5e39560b0be5e4330259686"><gtr:id>caf3d032b5e39560b0be5e4330259686</gtr:id><gtr:otherNames>Sarkar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_14722_22_23861669</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B91BF8F9-D814-454F-A730-FA32D14EFB88</gtr:id><gtr:title>Requirement for DNA ligase IV during embryonic neuronal development.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8a1b503a59c38adfb940af1e36afb58"><gtr:id>a8a1b503a59c38adfb940af1e36afb58</gtr:id><gtr:otherNames>Gatz SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pm_14722_22_21734301</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BB3B608-E8BF-44E3-87D7-F66FC1E6ACF3</gtr:id><gtr:title>Smc5/6 coordinates formation and resolution of joint molecules with chromosome morphology to ensure meiotic divisions.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09f4eb81b5d807b400de893db7e38c53"><gtr:id>09f4eb81b5d807b400de893db7e38c53</gtr:id><gtr:otherNames>Copsey A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>54516f620f9ae1.53814562</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>674D3A26-EE19-44A9-8E46-2C3FCA217F20</gtr:id><gtr:title>Distinct regulation of Mlh1p heterodimers in meiosis and mitosis in Saccharomyces cerevisiae.</gtr:title><gtr:parentPublicationTitle>Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b66fc5dc01e1fd5a85b8d79331e404e"><gtr:id>1b66fc5dc01e1fd5a85b8d79331e404e</gtr:id><gtr:otherNames>Cotton VE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0016-6731</gtr:issn><gtr:outcomeId>THtgwcvrvsa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D424B79-CB5E-4751-984F-9F095516FD75</gtr:id><gtr:title>SUMO meets meiosis: an encounter at the synaptonemal complex: SUMO chains and sumoylated proteins suggest that heterogeneous and complex interactions lie at the centre of the synaptonemal complex.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a8de5a144d713157188e483fd24be74"><gtr:id>3a8de5a144d713157188e483fd24be74</gtr:id><gtr:otherNames>Watts FZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>pm_14722_22_21590786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E22CB97-5F67-43D0-85D8-87012F4A720A</gtr:id><gtr:title>Gold amides as anticancer drugs: synthesis and activity studies.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caf2c5e128123ed9d1f2020fc3a8ad01"><gtr:id>caf2c5e128123ed9d1f2020fc3a8ad01</gtr:id><gtr:otherNames>Newcombe S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>pm_14722_22_23584015</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0902043</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>